Faculté de médecine, université de Poitiers, 86000 Poitiers, France; Service de maladies infectieuses et tropicales et médecine interne, CHU de Poitiers, 86000 Poitiers, France.
Service de maladies infectieuses et tropicales et médecine interne, CHU de Poitiers, 86000 Poitiers, France.
Med Mal Infect. 2019 Nov;49(8):586-592. doi: 10.1016/j.medmal.2019.09.004. Epub 2019 Sep 21.
Despite specific recommendations issued by the French Public Health Council (Haut Conseil de Santé Publique), the vaccination coverage of patients with cancer or malignant blood disease remains insufficient. The aim of this study was to assess the vaccination of chemotherapy patients by their general practitioner (GP).
A survey was conducted between March and July 2017 in 4 French departments to describe the immunization practices of GPs for their chemotherapy patients and provide solutions to help to increase the vaccination rate.
Of the 1610 GPs who received the questionnaire, 287 (17.8%) returned a usable form; 92.6% were globally pro-vaccine. One third of GPs (37.3%) declared that they vaccinated all their chemotherapy patients. The GPs (n=180) who never or only sometimes vaccinated their chemotherapy patients mainly voiced concerns about not being properly trained (45.6%) and the lack of easily available information on vaccination (35.0%). Three-quarters (n=212; 74%) of the GPs wanted to improve their level of medical knowledge via continuing education (52.4%) or by reading guidelines available on-line (39.6%). GPs suggested that a specific vaccination schedule be included in the letter they receive from the cancer specialist (72.8%) and that patient awareness be increased (50.5%).
GPs are in favor of the vaccination of cancer patients. The main obstacles stated are the lack of education and the lack of easily available information. Vaccination coverage could be increased by improving the doctor-to-doctor relation between GPs and cancer specialists.
尽管法国公共卫生理事会（Haut Conseil de Santé Publique）发布了具体建议，但癌症或恶性血液病患者的疫苗接种覆盖率仍然不足。本研究旨在评估全科医生（GP）为化疗患者接种疫苗的情况。
2017 年 3 月至 7 月在法国 4 个省进行了一项调查，以描述 GP 为化疗患者进行免疫接种的实践，并提供解决方案以帮助提高疫苗接种率。
在收到问卷的 1610 名全科医生中，有 287 名（17.8%）返回了可用表格；92.6%的全科医生总体上支持接种疫苗。三分之一的全科医生（37.3%）表示他们为所有化疗患者接种了疫苗。从不或仅偶尔为化疗患者接种疫苗的全科医生（n=180）主要表示对未接受适当培训（45.6%）和缺乏易于获取的疫苗接种信息（35.0%）感到担忧。四分之三（n=212；74%）的全科医生希望通过继续教育（52.4%）或阅读在线提供的指南（39.6%）来提高他们的医学知识水平。全科医生建议在他们从癌症专家那里收到的信中纳入特定的疫苗接种计划（72.8%），并提高患者的认识（50.5%）。
全科医生支持为癌症患者接种疫苗。他们表示的主要障碍是缺乏教育和缺乏易于获取的信息。通过改善全科医生与癌症专家之间的医患关系，可以提高疫苗接种覆盖率。
